Cargando…

Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment

At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenli, Hu, Enshi, Wang, Yajie, Miao, Si, Liu, Yanyan, Hu, Yumin, Liu, Ji, Xu, Bohui, Chen, Daquan, Shen, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423451/
https://www.ncbi.nlm.nih.gov/pubmed/34511911
http://dx.doi.org/10.2147/IJN.S311248
_version_ 1783749467999043584
author Zhang, Wenli
Hu, Enshi
Wang, Yajie
Miao, Si
Liu, Yanyan
Hu, Yumin
Liu, Ji
Xu, Bohui
Chen, Daquan
Shen, Yan
author_facet Zhang, Wenli
Hu, Enshi
Wang, Yajie
Miao, Si
Liu, Yanyan
Hu, Yumin
Liu, Ji
Xu, Bohui
Chen, Daquan
Shen, Yan
author_sort Zhang, Wenli
collection PubMed
description At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiotic delivery system to improve drug delivery behavior, in order to delay the generation of bacterial drug resistance. In recent years, with the continuous development of nanotechnology, various types of nanocarriers that respond to the infection microenvironment, targeting specific bacterial targets, and targeting infected cells, and so on, are gradually being used in the delivery of antibacterial agents to increase the concentration of drugs at the site of infection and reduce the side effects of drugs in normal tissues. Here, this article describes in detail the latest research progress on nanocarriers for antimicrobial, and commonly used targeted antimicrobial strategies. The advantages of the combination of nanotechnology and targeting strategies in combating bacterial infections are highlighted in this review, and the upcoming opportunities and remaining challenges in this field are rationally prospected.
format Online
Article
Text
id pubmed-8423451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84234512021-09-09 Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment Zhang, Wenli Hu, Enshi Wang, Yajie Miao, Si Liu, Yanyan Hu, Yumin Liu, Ji Xu, Bohui Chen, Daquan Shen, Yan Int J Nanomedicine Review At present, some bacteria have developed significant resistance to almost all available antibiotics. One of the reasons that cannot be ignored is long-term exposure of bacteria to the sub-minimum inhibitory concentration (MIC) of antibiotics. Therefore, it is necessary to develop a targeted antibiotic delivery system to improve drug delivery behavior, in order to delay the generation of bacterial drug resistance. In recent years, with the continuous development of nanotechnology, various types of nanocarriers that respond to the infection microenvironment, targeting specific bacterial targets, and targeting infected cells, and so on, are gradually being used in the delivery of antibacterial agents to increase the concentration of drugs at the site of infection and reduce the side effects of drugs in normal tissues. Here, this article describes in detail the latest research progress on nanocarriers for antimicrobial, and commonly used targeted antimicrobial strategies. The advantages of the combination of nanotechnology and targeting strategies in combating bacterial infections are highlighted in this review, and the upcoming opportunities and remaining challenges in this field are rationally prospected. Dove 2021-09-03 /pmc/articles/PMC8423451/ /pubmed/34511911 http://dx.doi.org/10.2147/IJN.S311248 Text en © 2021 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Zhang, Wenli
Hu, Enshi
Wang, Yajie
Miao, Si
Liu, Yanyan
Hu, Yumin
Liu, Ji
Xu, Bohui
Chen, Daquan
Shen, Yan
Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title_full Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title_fullStr Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title_full_unstemmed Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title_short Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment
title_sort emerging antibacterial strategies with application of targeting drug delivery system and combined treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423451/
https://www.ncbi.nlm.nih.gov/pubmed/34511911
http://dx.doi.org/10.2147/IJN.S311248
work_keys_str_mv AT zhangwenli emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT huenshi emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT wangyajie emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT miaosi emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT liuyanyan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT huyumin emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT liuji emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT xubohui emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT chendaquan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment
AT shenyan emergingantibacterialstrategieswithapplicationoftargetingdrugdeliverysystemandcombinedtreatment